Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Bullboard Posts (NDAQ:NVCN)

RE:Class action

you may have likely seen this since... https://neovasc.com/newsreleases/neovasc-announces-complete-dismissal-of-securities-class-action...
Monty2469 - March 7, 2022

Neovasc Reducer™ Demonstrates Cost Savings

VANCOUVER and MINNEAPOLIS, Feb. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the...
Betteryear2 - February 4, 2022

Class action

Anyone know of any updates on the proposed class action against Neovasc for the shoddy FDA application?
ENEMENEMYNEMO - August 30, 2021

Submission of COSIRA-II Protocol Supplement to FDA

VANCOUVER and MINNEAPOLIS, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company...
Betteryear2 - August 17, 2021

Time to Buy!

Any price below a dollar is a steal for this stock. At current levels it's a no brainer!
Dalahlama - April 16, 2021

2020 Rearview Mirror - Worthwhile

CC is usually good for uncommon insight https://www.channelchek.com/news-channel/What_Do_Investors_Look_At_
SmallCapPaul - December 29, 2020